The United Kingdom Private GP Electronic Health Record (EHR) market is projected to grow due to an increased demand for private GP services and technological advancements in healthcare. Despite potential challenges such as cyber-attacks and technical issues, integrating medical solutions with EHRs through technologies like AI and wearables will drive demand. The growth is also steered by the implementation of robust security measures complying with regulatory requirements.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
